Patents Assigned to Beijing Reciprocapharmaceuticals Co. Ltd.
  • Kinase inhibitor and method for treatment of related diseases
    Patent number: 9782406
    Abstract: Disclosed is a compound of (aminophenylamino) pyrimidyl benzamides and a synthesis method thereof. The compound has Btk-inhibition activity and can be used to treat autoimmune diseases, heteroimmune diseases, cancers or thromboembolic diseases.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: October 10, 2017
    Assignees: Peking University Shenzhen Graduate School, Beijing Reciprocapharmaceuticals Co., Ltd.
    Inventors: Zhengying Pan, Xitao Li
  • Kinase inhibitor and method for treatment of related diseases
    Patent number: 9150522
    Abstract: Disclosed is a compound of (aminophenylamino) pyrimidyl benzamides and a synthesis method thereof. The compound has Btk-inhibition activity and can be used to treat autoimmune diseases, heteroimmune diseases, cancers or thromboembolic diseases.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: October 6, 2015
    Assignees: Peking University Shenzhen Graduate School, Beijing Reciprocapharmaceuticals Co. Ltd.
    Inventors: Zhengying Pan, Xitao Li